GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00361-4/fulltext?dgcid=hubspot_update_feature_updatealerts_eclinm&utm_campaign=update-eclinm&utm_medium=email&_hsenc=p2ANqtz-_k5Q49g68DMJ2QdhDzPQHryCBkxmlEjVDriEC7zwOF3yQWk9WJFWs-MlrfTT6snJjIXzjkI4Wb2EzEKOC-bdUAMLb89A&_hsmi=328377271&utm_content=328320885&utm_source=hs_email